Evidence map›Paper›PMID 15638240›Full record

ReviewLipids2004

A review of tobacco BY-2 cells as an excellent system to study the synthesis and function of sterols and other isoprenoids.

Andréa Hemmerlin, Esther Gerber, Jean-François Feldtrauer, Laurent Wentzinger, Marie-Andrée Hartmann, Denis Tritsch, Jean-François Hoeffler, Michel Rohmer, Thomas J Bach

Abstract readReview
PubMed Publisher
In one paragraph

Review in Lipids, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Andréa HemmerlinCentre National de la Recherche Scientifique, Institut de Biologie Moléculaire des Plantes (UPR 2357), Département Fonctions et Biosynthèse des Isoprénoïdes, Université Louis Pasteur, F-67083 Strasbourg, France.
Esther Gerber
Jean-François Feldtrauer
Laurent Wentzinger
Marie-Andrée Hartmann
Denis Tritsch
Jean-François Hoeffler
Michel Rohmer
Thomas J Bach
Centre National de la Recherche Scientifique · FRInstitut pour l'avancée des biosciences · FRInstitut de Biologie Moléculaire des Plantes · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In plants, two pathways are utilized for the synthesis of isopentenyl diphosphate (IPP), the universal precursor for isoprenoid biosynthesis. In this paper we review findings and observations made primarily with tobacco BY-2 cells (TBY-2), which have proven to be an excellent system in which to study the two biosynthetic pathways. A major advantage of these cells as an experimental system is their ability to readily take up specific inhibitors and stably- and/or radiolabeled precursors. This permits the functional elucidation of the role of isoprenoid end products and intermediates. Because TBY-2 cells undergo rapid cell division and can be synchronized within the cell cycle, they constitute a highly suitable test system for determination of those isoprenoids and intermediates that act as cell cycle inhibitors, thus giving an indication of which branches of the isoprenoid pathway are essential. Through chemical complementation; and use of precursors, intracellular compartmentation can be elucidated, as well as the extent to which the plastidial and cytosolic pathways contribute to the syntheses of specific groups of isoprenoids (e.g., sterols) via exchange of intermediates across membranes. These topics are discussed in the context of the pertinent literature.

Indexed as

Cell LineModels, BiologicalNicotianaSterolsTerpenesSterolsTerpenes

Identifiers

PMID15638240
OpenAlexW1212244670

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.